The ethics of CRISPR gene editing with Jennifer Doudna

Jennifer Doudna, co-inventor of the CRISPR gene-editing technology, raises several important ethical questions about interfering with the human genome. While this technology opens up opportunities for treating genetic diseases, it also carries the potential for misuse, creating biological inequality, and having long-term impacts on future generations, necessitating close societal and scientific oversight.
Video Summary
AI GeneratedThe speaker expresses optimism about CRISPR technology's potential to improve human health while urging caution regarding its application. While genome editing in adults is viewed as a therapeutic tool similar to medication, the speaker warns against clinical use in human embryos due to the ethical implications of heritable genetic changes and the need for further global scientific consensus.
